Anti-alpha 1 Antichymotrypsin Antibody [B2C3]

Supplied through Antibodies.com, this primary monoclonal antibody (clone B2C3) is raised in mouse against human alpha 1 Antichymotrypsin (AACT/SERPINA3) and is intended for Western blot (WB) applications. The reagent is provided in lyophilised form at the 500 µg pack size and is unconjugated, with an IgG1 isotype, allowing straightforward secondary detection in standard WB workflows. Reactivity has been validated on human samples, and the immunogen is human plasma-derived α1-antichymotrypsin, with the hybridoma derived from the Sp2/0-Ag14 myeloma line. According to the Antibodies.com specification, shipping is dispatched from St. Louis, MO, with a typical lead time of 6–9 business days, and lyophilised stock should be reconstituted (commonly to ~1 mg/mL in distilled water) and stored at –20 °C for working aliquots. Target synonyms listed on Antibodies.com include AACT, ACT, Alpha-1-antichymotrypsin, Cell growth-inhibiting gene 24/25 protein, Serpin A3, and SERPINA3, and the product is labelled for research use only — not for diagnostic or therapeutic use. The same clone is also available from the supplier in a smaller 100 µg format for trial-scale work.